Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

22nd Century Appoints Larry Firestone as Chairman and CEO

GlobeNewswire November 29, 2023

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

GlobeNewswire November 27, 2023

22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores

GlobeNewswire November 8, 2023

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License

GlobeNewswire November 7, 2023

22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results

GlobeNewswire November 6, 2023

22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB

GlobeNewswire October 26, 2023

22nd Century Group (XXII) Reduces Debt by $8.1 Million

GlobeNewswire October 25, 2023

22nd Century Announces Pricing of $5.25 Million Public Offering

GlobeNewswire October 17, 2023

22nd Century Announces Proposed Public Offering

GlobeNewswire October 16, 2023

22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States

GlobeNewswire September 12, 2023

22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets

GlobeNewswire September 5, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

Newsfile August 22, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

PR Newswire August 18, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

Newsfile August 14, 2023

22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results

GlobeNewswire August 14, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

PR Newswire August 10, 2023

22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023

GlobeNewswire August 9, 2023

22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023

GlobeNewswire August 7, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

PR Newswire August 4, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII

Newsfile July 31, 2023